Empower Innovation with NIH: Opportunities in the US for Nordic Companies
Date
Location
Webinar
Time
16:48 – 16:48
Event type
Webinar
Organizer
CO-AX at Sahlgrenska Science Park
Learn how Nordic companies can successfully collaborate with NIH to make a meaningful impact in the US healthcare ecosystem.
Event information
CO-AX at Sahlgrenska Science Park invites you to an exclusive webinar with the National Institutes of Health (NIH) on January 21st, 2025.
Learn how Nordic companies can successfully collaborate with NIH to make a meaningful impact in the US healthcare ecosystem. This session will provide key insights into:
- NIH's research funding programs
- Opportunities for strategic partnerships
- Pathways for Nordic businesses to contribute to cutting-edge medical and healthcare advancements
Speaker: Michael L. Salgaller, Ph.D.
Don’t miss this chance to explore how your business can play a vital role in driving innovation on a global scale.
Date: January 21, 2025
Time: 15.00-16.00
Location: Online (Link provided upon registration)
Join us and take the first step toward impactful collaboration!
======
About National Institutes of Health
The National Institutes of Health (NIH), world’s largest biomedical research institute, could bring value to your company in ways you may not be aware. Beyond grant funding NIH’s mission includes facilitating technology and economic development. The NIH has established itself as open for business – as one of the go-to places for the healthcare industry to work with a thought-leader, overcome a technology or knowledge gap, and get their products to market. Beyond drugs, NIH develops devices, diagnostics, and digital health solutions. Competitive in equity, royalties, and overhead, NIH is a vital partner for businesses seeking to enhance pipelines, overcome knowledge gaps, and drive economic growth. NIH collaborates with companies to accelerate technology development and bring products to market.
About Michael L. Salgaller, Ph.D.
Dr. Michael Salgaller leads the Technology Analysis and Marketing Unit (TAMU) within the NIH’s Technology Transfer Office, where he leverages over 20 years of business, scientific, and investment experience in various life science sectors to support technology development and commercialization. The TAMU serves in a business development role to foster licensing and collaborative activity between buy-side stakeholders and the NIH.